← Open Payments lookup

HARA OYEDEJI: Open Payments

NPI 1497279053 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269,482 in 341 payments from 15 companies in 2025. Trend: 2023 $178,863 · 2024 $263,988 · 2025 $269,482

Speaker / faculty: $150,621Consulting: $64,616Travel & lodging: $34,914Honoraria: $10,000Food & beverage: $9,331
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.116$115,801
Alkermes, Inc.108$59,095
Neurocrine BioSciences, Inc.52$49,555
Teva Pharmaceuticals USA, Inc.15$18,974
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$13,236
Luye Pharma (USA) Ltd.7$11,277
Axsome Therapeutics, Inc.6$569
ABBVIE INC.2$324
Celgene Corporation2$180
Lundbeck LLC1$137

Products named: COBENFY, INGREZZA, LYBALVI, ARISTADA, UZEDY, CAPLYTA, ERZOFRI EXTENDED-RELEASE, Auvelity.

Industry payments across MD — which companies pay providers there.